Kathy V. Turner - Aug 31, 2021 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Senior Vice President
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Kathy V. Turner
Stock symbol
IDXX
Transactions as of
Aug 31, 2021
Transactions value $
$99,902
Form type
4
Date filed
9/2/2021, 05:03 PM
Previous filing
Aug 31, 2021
Next filing
Feb 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $99.9K +1.26K +43.68% $79.54* 4.13K Aug 31, 2021 Direct
holding IDXX Common Stock 100 Aug 31, 2021 by spouse F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Incentive Stock Option (right-to-buy) Options Exercise -1.26K -100% 0 Aug 31, 2021 Common Stock 1.26K $79.54 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial interest of the shares of common stock held by her spouse except to the extent of her pecuniary interest therein.
F2 Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 628 shares on February 14, 2020, without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
F3 Not applicable.